← FDA Drug Approvals (Drugs@FDA)
LINEZOLID
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS · Approved 2022-10-31
Drug application
- FDA Application #
ANDA211813- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LINEZOLID
- Generic name
- LINEZOLID
- Active ingredients
- LINEZOLID
- Dosage form
- FOR SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- HETERO LABS
- Manufacturer
- Camber Pharmaceuticals, Inc.
- First approval
- 2022-10-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown